In the first quarter of fiscal 2025, HOLX is expected to have benefited from the strength of its core franchises.

Shares of Hologic Inc. HOLX shed 1.35% to $71.77 Tuesday, on what proved to be an all-around favorable trading session for ...

The most recent trading session ended with Hologic (HOLX) standing at $71.77, reflecting a -1.35% shift from the previouse trading day's closing. The stock's performance was behind the S&P 500's daily ...

This was the stock's second consecutive day of gains.

The U.S. Food and Drug Administration has sent a warning letter to Marlborough, Mass.-based medical technology company ...

Hologic Inc (HOLX) stock saw a modest uptick, ending the day at $71.02 which represents a slight increase of $0.32 or 0.45% from the prior close of $70.7. The stock opened at $70.45 and touched a low ...

Hologic is down approximately 20% from recent highs and continues to grow organically and via a series of 'bolt-on' ...

Hologic (HOLX) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock. Over ...

In the closing of the recent trading day, Hologic (HOLX) stood at $71.19, denoting a +1.17% change from the preceding trading day.

The Hologic Women’s Health Index’s 2023 data found a decrease in testing for any cancer among women — a first in the survey’s ...

Needham analyst Michael Matson maintained a Buy rating on Hologic (HOLX – Research Report) today and set a price target of $90.00.Stay Ahead of ...

Leerink Partners analyst Puneet Souda maintained a Buy rating on Hologic (HOLX – Research Report) yesterday and set a price target of $80.00.